India Pharma Outlook Team | Wednesday, 01 June 2022
Sanofi India announced the appointment of Preeti Futnani as the Company’s General Manager – Vaccines, with effect from June 1, 2022. This marks her transition from being the Franchise Head for Dupixent Dermatology at Sanofi’s Greater Gulf MCO. She will now be based in Mumbai, India.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas and functions within healthcare, including primary and specialty care, medical technology, and finance.
She started her journey with Sanofi over six years ago in Specialty Care Gulf, after various roles of increasing responsibility in Novartis marketing and commercial operations across Switzerland, the UK, and India. She has held leadership roles in marketing, sales, and management across several geographies from mature markets in the UK and the EU to emerging markets in Asia and the Middle East.
Futnani succeeds Annapurna Das, who is elevated to Head of Vaccines, Asia. Das is delighted to have Futnani as GM, Vaccines and said “Her global experience is an asset that will further sharpen Sanofi India’s focus of increasing vaccine coverage rates by driving the growth of our current portfolio and accelerating launch of innovative vaccines in the country.”
, CDSCO.jpg)
